Clinical Trial Update: A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany

View source ↗

Summary

Non-interventional observational study in Germany to evaluate the long-term efficacy and safety of dupilumab for eosinophilic esophagitis under real-world condi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Eosinophilic Esophagitis | Status: RECRUITING